ACE2 and non-small cell lung carcinoma: High levels of ICOS may explain the predisposition to an inflammatory/cytokine over-reaction in patients with higher ACE2 expression, which may in turn underlie the more serious manifestations of COVID-19 pneumonia in individuals with NSCLC.